valuation_biotech

io.github.simonmak-ascent/startup-valuation · Verify this server

Risk-adjusted biotech valuation: peak sales, decision-tree expected value, and full pipeline rNPV across drugs. Method selects the model. Use for pharma/drug pipelines; for hardware or deep tech use valuation_hardware. Parameters apply per method: peak_sales needs patient_population + penetration + price; decision_tree needs probabilities + terminal_value; pipeline needs drugs + discount_rate. Not for hardware or deep tech — for that use valuation_hardware. Only method is required; all other parameters are method-dependent, so supply those the selected method names and omit the rest (defaults apply where defined). Rate and decimal inputs are fractions (0.10 = 10%); probability and weight lists are in [0,1] and sum to 1. Returns value, method, inputs, assumptions, chapter, formula_number and calculation steps; pure arithmetic — no I/O and no external calls — rounded to 2 decimals, with no auth or rate limits. An unknown method, or a missing method-required parameter, returns an error instead of a value.